CLINICAL NEWS
Doctors debate whether men with elevated cholesterol who are otherwise healthy should still take statins, in a new series in JAMA, Dueling Viewpoints. » More |
CONTINUING EDUCATION
E-prescribing, a paperless, real-time transmission of data, places pharmacists squarely within the healthcare technology team.
To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login. |
CLINICAL NEWS
A set of 11 evidence-based recommendations for managing pain with pharmacotherapy in patients suffering inflammatory arthritis were reported by an international panel online March 24 in Rheumatology. » More |
ADVERTISEMENT
Medical Economics 2012 EHR Web Seminar Series
Get ready for health information technology changes without losing focus on running your practice! This series offers guidance on implementation, compliance, choosing EHRs and more.  www.medec.com/ehrwebseminars |
EDITOR’S PICK
PCORI taps pharmacists, others in healthcare arena, for research ideas
The Patient-Centered Outcomes Research Institute has issued the first draft of its Priorities for Research and Research Agenda and is looking for input from the public and from the healthcare community. » Click here. |
CLINICAL NEWS
Phthalate metabolites, chemicals commonly used in plastics, cosmetics, and pharmaceuticals, were linked to an increased risk for the development of type 2 diabetes in the elderly, a recent study found. » More |
|
The supplementation with omega-3 fatty acids has no benefit in treating multiple sclerosis, according to a clinical trial that appeared in the JAMA’s Archives of Neurology. However, researchers acknowledged the randomized controlled trial was underpowered. » More |
FDA ACTIONS
The labels of 2 formulations of finasteride, used to treat enlarged prostate and male-pattern baldness, are being revised to indicate that additional sexual side effects may persist after the drug has been discontinued, FDA announced. » More |
Survey
a) Aging US population
b) Expanded coverage via HC reform
c) Price inflation by drug manufacturers
d) Growth in the specialty drug market
e) Increased incidence of key chronic diseases (eg, diabetes, CAD, asthma/COPD, etc.)
Click here and see what your colleagues think, too.
Want to see the results of our last survey regarding Medicare's coverage policy of immunosuppressive therapy following kidney transplantation? Click here. |
|
Confirm your
e-newsletter subscription click here.
To ensure future delivery of email newsletters from Formulary please take a moment to confirm your subscription by clicking here.
Thank you,
Formulary Staff |
Digital Edition |
|
|
|
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
|
